EP1140114 - Bibliographic data

PHARMACEUTICAL FORMULATIONS

Last update	24/05/2025
Legal status	Brevet déchu
Origin	Euro-PCT

(73) Holder	GILEAD SCIENCES, INC. 333 Lakeside Drive Foster City CA 94404 États-Unis d'Amérique
(72) Inventors	DAHL, Terrence, C. 1646 Kennewick Drive Sunnyvale, CA 94087 États-Unis d'Amérique YUAN, Lung-Chi, J. 207 Town Green Lane Foster City, CA 94404 États-Unis d'Amérique
(74) Agent	Mail recipient KINZEBACH, WERNER ET AL Reitstötter, Kinzebach & Partner Patentanwälte Sternwartstrasse 4 81679 MUNCHEN Allemagne

(21) Request number	EP99967310.6
(22) Request date	14/12/1999

(11) Publication number	EP1140114
Publication date	29/06/2005

(54) Title of the invention	PHARMACEUTICAL FORMULATIONS
(51) International classification	None
International classification (before reform)	, , ,

Claimed priority	(31) Number: 211613 (32) Date: 15/12/1998 (33) Country: US (31) Number: 112403 P (32) Date: 15/12/1998 (33) Country: US
Initial application	None
Divisional application	None

Expected annuity	Annuity: 7 - Amount: 83 € - Due date 03/01/2006
Last annuity	None

Publication	BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2005/2, of 30/06/2005
History	Publication de la délivrance du brevet européen - Legal date 29/06/2005 Déchéance du brevet d'invention après période de grâce - Legal date 31/12/2005